Background
==========

Acute Respiratory Distress Syndrome (ARDS) and Acute Lung Injury (ALI) affect 100,000-150,000 patients each year in the United States alone \[[@B1],[@B2]\]. ALI is an inflammatory syndrome characterized by acute respiratory failure due to non-cardiogenic pulmonary edema and hypoxemia \[[@B3]\]. Oxidant stress caused by reactive oxygen species (ROS) is thought to be a major contributor to the pathogenesis of ALI. ROS can be generated by inflammatory cells or pulmonary endothelium and cause damage to proteins, DNA, and lipids \[[@B4]\].

The risk of developing ALI/ARDS is not uniformly distributed in the critically ill population, suggesting a genetic influence on outcomes \[[@B5]\]. Peroxiredoxins are a superfamily of non-heme and non-selenium peroxidases that are widely distributed throughout all phyla \[[@B6]\]. The Peroxiredoxin 6 gene (*PRDX6*) is located on chromosome 1q24 and is approximately 12 Kb in length, containing 5 exons. The Prdx6 protein encoded by *PRDX6*is involved in redox regulation of the cell and has been shown in cell and animal models to be protective against oxidative injury \[[@B7]\]. Prdx6 also has phospholipase A~2~activity and has an important role in lung surfactant metabolism \[[@B7]\]. The protein product, Prdx6, has been shown to affect the cellular level of H~2~O~2~produced in cells stimulated with platelet-derived growth factor or tumor necrosis factor-α, and modulating signaling induced by those ligands \[[@B8]\], thus indicating that Prdx6 can have an effect on cytokine levels and cell signaling cascades. Recent studies suggest that Prdx6 is only active following heterodimerization with glutathione-S-transferase pi, indicating that there is an important interaction between Prdx6 and GSTpi \[[@B6]\]. Despite these important functions, little is known about genetic variation within the *PRDX6*gene \[[@B9]\] and its association with ALI.

In order to determine if variation within *PRDX6*is associated with ALI risk in either the African American (AA) or European American (EA) populations, we performed direct sequencing of the 5\' UTR, exons, introns, and the 3\' untranslated region (UTR) in 48 subjects (25 African Americans and 23 European Americans) and identified 80 variants, many of which have not been previously reported. Eighteen of the eighty variants, along with 19 tagging SNPs selected using HapMap <http://hapmap.ncbi.nlm.nih.gov/>, were tested for association with ALI using a custom genotyping platform.

Methods
=======

Patient population
------------------

Between 1999 and 2006, patients were enrolled in a major trauma cohort study designed to study molecular risks for acute lung injury \[[@B10]-[@B12]\]. Participants met the following inclusion criteria: 1) admission to the intensive care unit (ICU) as a result of acute trauma directly from the field or via that hospital\'s Emergency Department; and 2) have an Injury Severity Score (ISS) ≥ 16 as calculated on the basis of information available during their first 24 hours of hospitalization. The following demographic and clinical variables were collected upon admission to the ICU: age, gender, ISS, blunt mechanism, and acute physiology and chronic health evaluation (APACHE) (Table [1](#T1){ref-type="table"}). Exclusion criteria were death or discharge from the ICU within 24 hours of admission, less than 13 years of age, current or past evidence of congestive heart failure (CHF) or recent acute myocardial infarction, severe chronic respiratory disease, morbid obesity, burns on over 30% of the total body surface area, and lung or bone marrow transplant \[[@B10]\].

###### 

Clinical data for individuals enrolled in the study by ancestry

  --------------------------------------------------------------
                                     ALI           No ALI
  ---------------------------------- ------------- -------------
  **African Americans (N = 285)**    (N = 71)      (N = 187)

   Age (± SD)                        36.7 ± 17.5   31.9 ± 12.4

   Gender (% of males )              32            84

   ISS (± SD)                        25.3 ± 8.9    22.8 ± 6.3

   Blunt Mechanism (%)\              25            59
  (% of Blunt Trauma)                              

   APACHE (± SD)                     45.4 ± 12.4   40.2 ± 13.5

  **European Americans (N = 269)**   (N = 86)      (N = 168)

   Age (± SD)                        41.8 ± 19.9   39.3 ± 18.5

   Gender (% of males )              27            61

   ISS (± SD)                        26.9 ± 7.5    25.2 ± 7.2

   Blunt Mechanism (%)               4             7

   APACHE (± SD)                     41.9 ± 14.7   35.7 ± 12.8
  --------------------------------------------------------------

The definition of ALI was in accordance with the American European Consensus Conference (AECC) \[[@B3]\]. ALI and ARDS were defined as: acute onset; bilateral pulmonary infiltrates on chest X-ray consistent with pulmonary edema; absence of evidence of left atrial hypertension; and poor systemic oxygenation, and a ratio of arterial oxygen (PaO2) to the fraction of inspired oxygen (FiO2) less than or equal to 300 for ALI and 200 for ARDS \[[@B3]\]. All chest x-rays were reviewed independently by 2 trained observers. In our population, greater than 85% of subjects meeting criteria for ALI also met criteria for ARDS.

Clinical Data and Biosample Collection
--------------------------------------

Clinical data were collected by trained study nurses using a standardized research case report form designed for the trauma cohort study. Blood for analysis was obtained from residual blood samples in tubes containing ethyledenediaminetetraacetic acid (EDTA) that had been previously drawn for other clinical purposes. Study personnel collected residual samples each day, centrifuged, and separated the buffy coat layers, which were frozen at -80°C \[[@B10]\]. All clinical and biosample collection protocols were approved by the institutional review board (IRB) at the University of Pennsylvania School of Medicine under a waiver of informed consent.

*PRDX6*resequencing
-------------------

Genomic DNA was extracted from whole blood using Qiagen Qiamp DNA Blood Midi Kits (Qiagen USA) and stored in the provided tris-EDTA buffer. DNA from 25 African American and 23 European American subjects selected from the major trauma cohort, with ALI status equally distributed within each group, were selected for sequencing of PCR fragments, providing a power of 99% to detect minor allele frequencies of at least 5% \[[@B13]\]. PCR primers for 4 Kb upstream of the ATG start site, all exons, introns, and 4 Kb of the 3\' UTR were designed using PCRoverlap (Children\'s Hospital of Philadelphia (CHOP) bioinformatics core) to generate amplicons between 600 and 800 bp that overlapped by at least 100 bp (Additional file [1](#S1){ref-type="supplementary-material"}). Following primer optimization, DNA was amplified and sequenced in the forward and reverse direction using a 3730 automated sequencer at the CHOP Nucleic Acid and Protein Core facility (Philadelphia, PA). Sequencher 4.8 (Gene Codes Ann Arbor, MI) was used to facilitate secondary peak calls and to compare the sequence data to the NCBI reference sequence.

SNP genotyping
--------------

Novel variants with a minor allele frequency (MAF) of 0.04 or higher and tagging SNPs, from HapMap <http://hapmap.ncbi.nlm.nih.gov/>, were validated using the SNPlex genotyping system (Applied Biosystems Inc. Foster City, CA). Tagging SNPs were selected using Tagger\'s pairwise testing methods described by Bakker and colleagues \[[@B14]\]. Genotyping novel variants not only served to test for association, but allowed us to validate those SNPs in a larger population. Tagging SNPs were also selected to provide better coverage of the haplotype structure of *PRDX6*. SNPlex utilizes an oligonucleotide ligation/PCR assay with universal ZipChute probe detection to perform genotyping of up to 48 SNPs in a single reaction. ZipChute probes were custom designed and detected by capillary electrophoresis using the Applied Biosystems 3130 Analyzer and genotype calls were determined using Gene Mapper 4.0 (Applied Biosystems Foster City, CA).

All genotyping was performed in the University of Pennsylvania\'s Laboratory for Molecular Epidemiology (LME). Staff was blinded to the disease status and genotyping calls were performed in subsamples by plate. Each plate contained six positive controls to test for concordance. Genotyping calls were performed automatically using the algorithm described by Da La Vega and colleagues \[[@B15]\].

*In silico*modeling of putative function in SNP sites
-----------------------------------------------------

We sought to test inferred function *in silico*using transcription factor binding and mRNA binding tools. TESS is a web-based software tool for locating possible transcription factor binding sites in DNA sequences using weight matrix models. It can also be used for browsing information about relevant transcription factors in the TRANSFAC database \[[@B16]\]. All SNPs discovered within the 5\' UTR and the first intron were submitted to TESS as 21 base pair long FASTA sequences with the reference allele of the SNP of interest in the 11^th^position. A second search was performed using the alternative allele in the 11^th^position. To eliminate any poor matches due to background noise, transcription factors with log-likelihood scores (La) less than 12, were eliminated. TESS results were compared with experimental transcription factor binding site (TFBS) data registered in the University of California Santa Cruz (UCSC) Genome Browser by the Encyclopedia of DNA Elements (ENCODE) consortium \[[@B17]\]. The ENCODE data were filtered by chromosome and position.

A search query was performed for potential miRNA binding sites in the 3\' UTR of *PRDX6*using Patrocles <http://www.patrocles.org/>. Patrocles is an online database containing DNA sequence polymorphisms that are predicted to interrupt miRNA-mediated gene regulation \[[@B18]\]. The search was performed using \"*PRDX6*\" as a key word in the target gene id field and miRNA target motifs were defined by Xie *et al.*\[[@B19]\] and Lewis *et al*\[[@B20]\].

Statistical Analysis of ALI association
---------------------------------------

259 African American and 254 European American subjects enrolled in the major trauma cohort were used to test for association of novel variants and tagging SNPs with ALI. Association of each *PRDX6*SNP with ALI was determined separately for European Americans and African Americans using an additive model Chi^2^test, with a p-value \< 0.0014 for African Americans considered significant. Dominant and recessive inheritance models were also tested using Chi^2^analysis. Multivariable analyses of potential confounding were performed using logistic regression methods. Power was calculated using the power for genetic association analyses (PGA) \[[@B21]\]. Using PGA, we estimated that a sample size of 250 subjects per race category would provide 80% power to detect relative risks of 2.26 or greater for SNPs with a prevalence of 0.05 or greater and 1.93 or greater for SNPs with a prevalence of 0.10 or greater, assuming a Bonferroni-corrected alpha = 0.0014 for African Americans, and an incidence of ALI = 0.30 (Additional file [2](#S2){ref-type="supplementary-material"}). These statistical analyses were performed using STATA 11 (STATA Data Corp, College Station, TX). Pairwise linkage disequilibrium was evaluated using Haploview <http://www.broadinstitute.org/mpg/haploview>. Genotypes with a completion rate of 95% or greater were considered for analysis in Haploview. LD was calculated in terms of r^2^values and blocks were defined using the default algorithm using the confidence intervals methods of Gabriel and colleagues \[[@B22]\].

Haplotypes were inferred using the standard expectation maximization algorithm in Haploview \[[@B23],[@B24]\] and the following confidence interval (CI) criteria: CI minima for strong LD: 0.7 - 0.98; upper CI maximum for strong LD: 0.98; fraction of strong LD in informative comparisons ≥ 0.95; and exclude markers with minor allele frequency (MAF) \< 0.05. Haplotypes were tested for association with ALI first in a global association test, which performed contingency testing using all haplotypes of an LD block compared to no haplotypes, and then as individual haplotypes versus ALI coded in an additive fashion PLINK \[[@B25]\]. Haplotype multiple testing was addressed by applying permutation tests (10,000 permutations).

Results
=======

Identification of novel polymorphisms in *PRDX6*
------------------------------------------------

Direct sequencing of the *PRDX6*gene in 48 subjects revealed 80 genetic variants, none of which were in coding regions (31 in the 3\' UTR, 22 in the 5\' UTR and 27 intronic) (Additional file [3](#S3){ref-type="supplementary-material"}). The variants identified via direct sequencing were compared with those registered in the NCBI dbSNP database (Build 130) and 43 were found to be novel SNPs (Table [2](#T2){ref-type="table"}). Thirty seven were matched with SNPs catalogued in dbSNP (Build 130) and Genewindow <http://genewindow.nci.nih.gov/Welcome> based on chromosome position (Table [3](#T3){ref-type="table"}). Twenty five of the novel SNPs uncovered had a MAF \> 0.04 and were submitted to the NCBI to be catalogued and assigned ss numbers in the submitter records section of dbSNP (Table [2](#T2){ref-type="table"}). Novel SNPs were also compared with SNPs registered in the 1000 Genomes database. Thirty six out of thirty seven known SNPs overlapped with SNPs registered in 1000 Genomes, but only sixteen out of forty-three novel SNPs identified via our sequencing effort were also registered in 1000 Genomes (Table [4](#T4){ref-type="table"}). Several variants were only observed in one individual. As a quality control measure we present the confidence scores for these genotypes in additional file [4](#S4){ref-type="supplementary-material"}. Confidence scores are reported as the percentage of overlap between heterozygote peaks. Previous studies indicated that two transcription factor binding sites, the ARE1 (-357 to -349) \[[@B26]\] and GRE2 (-750 to -738) (A. Fisher, unpublished observations), may play a role in the regulation of *PRDX6*. We were unable to sequence the ARE1 region and portions of the intronic regions due to the GC rich content of the flanking sequence (Figure [1](#F1){ref-type="fig"}). The GRE2 region was successfully sequenced, but showed no variation.

###### 

Novel SNPs discovered via direct sequencing

  Novel SNPs        Region    Chr. Position   SNP   5\' Flanking Sequence   3\' Flanking Sequence   MAF in EA   MAF in AA   ss\# (dbSNP)
  ----------------- --------- --------------- ----- ----------------------- ----------------------- ----------- ----------- --------------
  PRDX6_171709541   5\' UTR   171709541       G/C   CTTCAAGGTTC             ACCCTTATAGC             0.04        0.02        ss217326279
                                                                                                                            
  PRDX6_171709910   5\' UTR   171709910       G/T   ATGATCATTTTT            GAAATATACAG             0.00        0.10        ss217326288
                                                                                                                            
  PRDX6_171710327   5\' UTR   171710327       C/T   ACCCTAGCCCC             TGTGCTGGCA              0.04        0.00        ss217326273
                                                                                                                            
  PRDX6_171710490   5\' UTR   171710490       C/T   TGCACTGCGGA             GCAGGGACCT              0.00        0.06        ss217326283
                                                                                                                            
  PRDX6_171710775   5\' UTR   171710775       G/C   CTTATGGCTGG             GTGAGACATG              0.00        0.02        
                                                                                                                            
  PRDX6_171710821   5\' UTR   171710821       C/T   ACTGCACTGAG             TTGTGTAAAGT             0.00        0.10        ss217326292
                                                                                                                            
  PRDX6_171711029   5\' UTR   171711029       C/T   ACTCAGAGACC             GGGTCCTCCG              0.00        0.02        
                                                                                                                            
  PRDX6_171712345   5\' UTR   171712345       A/T   ATGGTTCATAA             AGAAAGGGGA              0.87        0.64        ss217326296
                                                                                                                            
  PRDX6_171713694   intron    171713694       G/T   TCACTTCCCCG             AGTGCCCAGG              0.00        0.04        ss217326300
                                                                                                                            
  PRDX6_171713738   intron    171713738       G/T   CCTCCGTTCTG             TGCTCCCTGG              0.00        0.02        
                                                                                                                            
  PRDX6_171713872   intron    171713872       C/T   GCACAAAATGT             TAAAACCACTA             0.00        0.12        ss217326323
                                                                                                                            
  PRDX6_171713919   intron    171713919       G/C   AAAGACTTTTTG            AGCCGCCTCC              0.02        0.00        
                                                                                                                            
  PRDX6_171714107   intron    171714107       C/T   CCAGGACACGT             TCCCCAACTTT             0.00        0.04        ss217326304
                                                                                                                            
  PRDX6_171714984   intron    171714984       C/T   GATCAAAAGTG             TTATCAGGGAG             0.04        0.04        ss217326307
                                                                                                                            
  PRDX6_171715019   intron    171715019       A/G   AGGAACACGGT             TATCTGCATTT             0.00        0.10        ss217326318
                                                                                                                            
  PRDX6_171715596   intron    171715596       A/G   GGGAGGGAAG              TGAACTGGCTT             0.00        0.02        
                                                                                                                            
  PRDX6_171716007   intron    171716007       A/G   AAACCTTGGGA             GTGGCAGCCG              0.00        0.04        ss217326311
                                                                                                                            
  PRDX6_171716032   intron    171716032       G/C   TAAGTAGGAAG             TGCCCTTGTCT             0.00        0.02        
                                                                                                                            
  PRDX6_171716554   intron    171716554       A/C   AGAAGCCAAGT             AACTTTAATTTT            0.00        0.02        
                                                                                                                            
  PRDX6_171716572   intron    171716572       A/T   TCAACTTTAATT            TAAATAGAAGA             0.00        0.02        
                                                                                                                            
  PRDX6_171716582   intron    171716582       A/G   TTACATATAAAT            ATAGAAACCTA             0.00        0.04        ss217326315
                                                                                                                            
  PRDX6_171716584   intron    171716584       A/T   ACATATAAATAG            AGAAACCTATT             0.00        0.02        
                                                                                                                            
  PRDX6_171716603   intron    171716603       A/G   AACCTATTTATT            ATTACATAATTT            0.00        0.02        
                                                                                                                            
  PRDX6_171723151   Intron    171723151       C/T   AAAGCTAGCAT             TGGAGAAGAA              0.00        0.02        
                                                                                                                            
  PRDX6_171723403   Intron    171723403       C/T   CTTGATTAGTCT            AGCACCTGTAG             0.00        0.02        
                                                                                                                            
  PRDX6_171723889   3\'UTR    171723889       G/T   AAAACTCAAAT             GGATCTCTGCA             0.00        0.04        
                                                                                                                            
  PRDX6_171723918   3\'UTR    171723918       A/G   GCTTGTGACCA             GTCATATTTGT             0.00        0.02        
                                                                                                                            
  PRDX6_171724000   3\'UTR    171724000       G/C   TAACTGTCCTAT            TCCTCTCCTGT             0.00        0.04        ss217326227
                                                                                                                            
  PRDX6_171724128   3\'UTR    171724128       G/T   TTTTTTTAATAT            TGATCACAGAA             0.00        0.04        ss217326232
                                                                                                                            
  PRDX6_171724182   3\'UTR    171724182       A/G   CATATTCTTTTA            TCTTGATCACA             0.00        0.04        ss217326236
                                                                                                                            
  PRDX6_171724286   3\'UTR    171724286       A/T   TTGCTATAAAAA            TTTGTGATAAG             0.00        0.02        
                                                                                                                            
  PRDX6_171724949   3\'UTR    171724949       C/T   ACTCTACTAATA            CAGGTTTAGAA             0.26        0.00        ss217326270
                                                                                                                            
  PRDX6_171725122   3\'UTR    171725122       G/T   GGACCTGCTTC             TTGTAGTTTGC             0.00        0.04        ss217326239
                                                                                                                            
  PRDX6_171725183   3\'UTR    171725183       C/T   GGGATCATCGC             GTCTCATAAGG             0.00        0.04        ss217326242
                                                                                                                            
  PRDX6_171725257   3\'UTR    171725257       A/T   CCTCCCAAAGG             CATCCAAATAC             0.00        0.04        ss217326247
                                                                                                                            
  PRDX6_171725485   3\'UTR    171725485       C/T   CCTGCCTCAGC             GAGCAGCTGG              0.00        0.06        ss217326250
                                                                                                                            
  PRDX6_171725681   3\'UTR    171725681       G/T   ATATTTTTATTG            TAGAATAATGT             0.00        0.02        
                                                                                                                            
  PRDX6_171725826   3\'UTR    171725826       A/G   TCTGGGGAATG             TTTGAAAGAGA             0.04        0.00        ss217326254
                                                                                                                            
  PRDX6_171727146   3\'UTR    171727146       G/C   CTGTGATTCCT             TTGTGGTCTTG             0.02        0.00        
                                                                                                                            
  PRDX6_171727831   3\'UTR    171727831       C/T   ATGCATGGGAT             ATTATCCTCTA             0.04        0.02        ss217326261
                                                                                                                            
  PRDX6_171728416   3\'UTR    171728416       G/T   CCTCATTAGGG             CTCTTAGCCCT             0.04        0.02        ss217326266
                                                                                                                            
  PRDX6_171728455   3\'UTR    171728455       G/C   AATCGGGAGGC             TGTTAACAGGT             0.00        0.04        ss217326257
                                                                                                                            
  PRDX6_171729049   3\'UTR    171729049       C/T   GTTCTTAAACTA            AATAGCATGAG             0.00        0.02        

###### 

Known SNPs discovered via direct sequencing

  Knowns SNPs   Region    Chr. Position   SNP     MAF in EA (discovery)   MAF in AA (discovery)   MAF in EA (dbSNP)   MAF in AA (dbSNP)
  ------------- --------- --------------- ------- ----------------------- ----------------------- ------------------- -------------------
  rs13376447    5\' UTR   171709896       A/G     0.00                    0.06                    0.01                0.09
                                                                                                                      
  rs10753081    5\' UTR   171710154       C/T     0.39                    0.30                    0.73                0.21
                                                                                                                      
  rs34282688    5\' UTR   171710819       C/T     0.07                    0.00                    NA                  NA
                                                                                                                      
  rs9425722     5\' UTR   171711268       C/T     1.02                    0.70                    0.04                0.24
                                                                                                                      
  rs35152701    5\' UTR   171711269       A/G     0.02                    0.00                    0.00                0.00
                                                                                                                      
  rs12739142    5\' UTR   171711278       A/G     0.04                    0.00                    0.02                0.04
                                                                                                                      
  rs4354572     5\' UTR   171711459       C/T     1.02                    0.66                    0.00                0.04
                                                                                                                      
  rs34619706    5\' UTR   171711670       A/G     0.09                    0.02                    0.07                0.04
                                                                                                                      
  rs4382766     5\' UTR   171711699       C/T     0.54                    0.28                    0.30                0.50
                                                                                                                      
  rs13376392    5\' UTR   171711701       C/T     0.00                    0.06                    0.00                0.04
                                                                                                                      
  rs11576174    5\' UTR   171712301       G/T     0.04                    0.00                    0.15                0.00
                                                                                                                      
  rs34977864    5\' UTR   171712466       G/T     0.00                    0.06                    0.00                0.10
                                                                                                                      
  rs35441546    5\' UTR   171712652       C/T     0.00                    0.06                    0.00                0.03
                                                                                                                      
  rs35133735    5\' UTR   171712738       C/T     0.00                    0.06                    0.00                0.00
                                                                                                                      
  rs6671141     intron    171713557       G/T     0.26                    0.26                    0.24                0.30
                                                                                                                      
  rs35749242    intron    171714171       A/G     0.00                    0.12                    0.00                0.03
                                                                                                                      
  rs35918328    intron    171714199       A/G     0.00                    0.02                    0.00                0.10
                                                                                                                      
  rs35899698    intron    171714279       C/T     0.00                    0.10                    0.00                0.00
                                                                                                                      
  rs33942654    intron    171714884       A/G     0.26                    0.18                    0.23                0.33
                                                                                                                      
  rs35679908    intron    171715013       A/G     0.00                    0.02                    0.00                0.00
                                                                                                                      
  rs9425723     intron    171715118       A/G     0.33                    0.62                    0.23                0.63
                                                                                                                      
  rs9425724     intron    171715123       A/G     0.33                    0.54                    0.23                0.53
                                                                                                                      
  rs7540065     intron    171715659       A/G     0.33                    0.56                    0.23                0.53
                                                                                                                      
  rs35244306    intron    171716247       C/T     0.00                    0.14                    0.00                0.07
                                                                                                                      
  rs4611        3\'UTR    171723640       C/T     0.33                    0.50                    0.77                0.47
                                                                                                                      
  rs3833536     3\'UTR    171724172       C/-     0.00                    0.00                    0.05                0.04
                                                                                                                      
  rs7314        3\'UTR    171724222       A/G     0.20                    0.50                    0.23                0.52
                                                                                                                      
  rs36005931    3\'UTR    171724224       A/G     0.00                    0.04                    0.00                0.10
                                                                                                                      
  rs2000        3\'UTR    171724457       A/G     0.04                    0.00                    0.03                0.00
                                                                                                                      
  rs34129563    3\'UTR    171724720       G/C     0.11                    0.00                    0.02                0.03
                                                                                                                      
  rs9425727     3\'UTR    171725216       G/C     0.02                    0.14                    0.00                0.04
                                                                                                                      
  rs35358649    3\'UTR    171725429       C/T     0.02                    0.00                    0.00                0.00
                                                                                                                      
  rs35547740    3\'UTR    171725569       (-/T)   0.00                    0.04                    0.00                0.07
                                                                                                                      
  rs6702835     3\'UTR    171725723       A/G     0.33                    0.48                    0.23                0.54
                                                                                                                      
  rs60587131    3\'UTR    171726777       G/C     0.00                    0.02                    0.05                NA
                                                                                                                      
  rs57032935    3\'UTR    171726836       G/C     0.15                    0.22                    0.18                0.31
                                                                                                                      
  rs6664925     3\'UTR    171729033       A/G     0.00                    0.18                    0.00                0.16

###### 

Comparison of PRDX6 discovery SNPs with 1000 Genomes database

  [PRDX6 SNPs]{.ul}   [1000 Genomes Comparison]{.ul}   [PRDX6 SNPs]{.ul}   [1000 Genomes Comparison]{.ul}
  ------------------- -------------------------------- ------------------- --------------------------------
  PRDX6_171709910     Matched                          PRDX6_171709541     Not Matched
                                                                           
  PRDX6_171713872     Matched                          PRDX6_171710327     Not Matched
                                                                           
  PRDX6_171714107     Matched                          PRDX6_171710490     Not Matched
                                                                           
  PRDX6_171723151     Matched                          PRDX6_171710775     Not Matched
                                                                           
  PRDX6_171723918     Matched                          PRDX6_171710821     Not Matched
                                                                           
  PRDX6_171724000     Matched                          PRDX6_171711029     Not Matched
                                                                           
  PRDX6_171724128     Matched                          PRDX6_171712345     Not Matched
                                                                           
  PRDX6_171724182     Matched                          PRDX6_171713694     Not Matched
                                                                           
  PRDX6_171725122     Matched                          PRDX6_171713738     Not Matched
                                                                           
  PRDX6_171725183     Matched                          PRDX6_171713919     Not Matched
                                                                           
  PRDX6_171725257     Matched                          PRDX6_171714984     Not Matched
                                                                           
  PRDX6_171725826     Matched                          PRDX6_171715019     Not Matched
                                                                           
  PRDX6_171727146     Matched                          PRDX6_171715596     Not Matched
                                                                           
  PRDX6_171727831     Matched                          PRDX6_171716007     Not Matched
                                                                           
  PRDX6_171728416     Matched                          PRDX6_171716032     Not Matched
                                                                           
  PRDX6_171728455     Matched                          PRDX6_171716554     Not Matched
                                                                           
  rs10753081          Matched                          PRDX6_171716572     Not Matched
                                                                           
  rs11576174          Matched                          PRDX6_171716582     Not Matched
                                                                           
  rs12739142          Matched                          PRDX6_171716584     Not Matched
                                                                           
  rs13376392          Matched                          PRDX6_171716603     Not Matched
                                                                           
  rs13376447          Matched                          PRDX6_171723403     Not Matched
                                                                           
  rs2000              Matched                          PRDX6_171723889     Not Matched
                                                                           
  rs33942654          Matched                          PRDX6_171724286     Not Matched
                                                                           
  rs34129563          Matched                          PRDX6_171724949     Not Matched
                                                                           
  rs34282688          Matched                          PRDX6_171725485     Not Matched
                                                                           
  rs34619706          Matched                          PRDX6_171725681     Not Matched
                                                                           
  rs34977864          Matched                          PRDX6_171729049     Not Matched
                                                                           
  rs35133735          Matched                          rs3833536           Not Matched
                                                                           
  rs35152701          Matched                                              
                                                                           
  rs35244306          Matched                                              
                                                                           
  rs35358649          Matched                                              
                                                                           
  rs35441546          Matched                                              
                                                                           
  rs35547740          Matched                                              
                                                                           
  rs35679908          Matched                                              
                                                                           
  rs35749242          Matched                                              
                                                                           
  rs35899698          Matched                                              
                                                                           
  rs35918328          Matched                                              
                                                                           
  rs36005931          Matched                                              
                                                                           
  rs4354572           Matched                                              
                                                                           
  rs4382766           Matched                                              
                                                                           
  rs4611              Matched                                              
                                                                           
  rs57032935          Matched                                              
                                                                           
  rs60587131          Matched                                              
                                                                           
  rs6664925           Matched                                              
                                                                           
  rs6671141           Matched                                              
                                                                           
  rs6702835           Matched                                              
                                                                           
  rs7314              Matched                                              
                                                                           
  rs7540065           Matched                                              
                                                                           
  rs9425722           Matched                                              
                                                                           
  rs9425723           Matched                                              
                                                                           
  rs9425724           Matched                                              
                                                                           
  rs9425727           Matched                                              

![**PRDX6 gene diagram with novel SNP positions**. A schematic of the PRDX6 gene is presented with vertical lines and arrows above the gene indicating novel SNPs and regions of interest, respectively. The horizontal arrows below the schematic are representative of the regions of PRDX6 that were successfully sequenced.](1471-2350-12-77-1){#F1}

*In Silico*function of novel SNPs in *PRDX6*
--------------------------------------------

The TESS results showed several potential transcription factor binding motifs in both the reference and alternative sequence. The reference and alternative sequences were submitted as independent queries and transcription factors were returned for 19 positions in the reference sequence and 21 positions in the alternative sequence (Table [5](#T5){ref-type="table"}). Twenty seven out of twenty nine sequences submitted were shown to create, abolish, or change a transcription factor binding site. Fourteen of these SNPs were novel. Comparison of the transcription factors returned from the TESS query with the data from ENCODE showed that only 3 of these putative transcription factor binding sites have been tested by the ENCODE consortium, SP1, GATA-1, and c-Myc. ENCODE data for SP1, GATA-1, and c-Myc revealed that there is no evidence of binding affinity with the sequence results from the PRDX6 gene when filtered for *PRDX6*and A549 cells.

###### 

Potential transcription factor binding sites within the PRDX6 gene

  SNP               Location   Base Change   Reference Sequence            Alternative Sequence
  ----------------- ---------- ------------- ----------------------------- ---------------------------------------------
  PRDX6_171709541   5\' UTR    G/C           n/a                           Sp1, CACCC binding factor, PuF
                                                                           
  rs13376447        5\' UTR    A/G           GATA-1                        GATA-1
                                                                           
  PRDX6_171709910   5\' UTR    G/T           n/a                           IL-6 RE-BP
                                                                           
  rs10753081        5\' UTR    C/T           GATA-3                        GATA-1
                                                                           
  PRDX6_171710327   5\' UTR    C/T           C/EBPbeta                     C/EBPbeta
                                                                           
  PRDX6_171710775   5\' UTR    G/C           c-Myb                         n/a
                                                                           
  rs9425722         5\' UTR    C/T           n/a                           c-Myc
                                                                           
  rs35152701        5\' UTR    A/G           n/a                           TMF, TBP, TFIID
                                                                           
  rs12739142        5\' UTR    A/G           IPF1, Isl-1, IPF1             IPF1
                                                                           
  rs4354572         5\' UTR    C/T           C/EBPbeta                     AFP1, ATBF1-B
                                                                           
  rs11576174        5\' UTR    G/T           H4TF-1                        ETF, TMF, TFIID, TBP
                                                                           
  PRDX6_171712345   5\' UTR    A/T           n/a                           SRY, TCF-4E
                                                                           
  PRDX6_171712345   5\' UTR    A/T           n/a                           SRY
                                                                           
  rs35441546        5\' UTR    C/T           Sp1, ETF                      CACCC-binding factor, Sp1
                                                                           
  rs35133735        5\' UTR    C/T           n/a                           CACCC-binding factor, Sp1
                                                                           
  rs6671141         intron     G/T           GR alpha, PR, PR A, GR beta   n/a
                                                                           
  PRDX6_171713738   intron     G/T           n/a                           TEF-1
                                                                           
  PRDX6_171713872   intron     C/T           n/a                           H4TF-1
                                                                           
  rs35918328        intron     A/G           IPF1                          n/a
                                                                           
  rs33942654        intron     A/G           c-Myb                         n/a
                                                                           
  PRDX6_171714984   intron     C/T           TBP                           GATA-1
                                                                           
  PRDX6_171715019   intron     A/G           GATA-3                        GATA-1
                                                                           
  rs9425723         intron     A/G           TBP, TFIID                    AP-1, c-Jun
                                                                           
  rs9425724         intron     A/G           USF1                          AP-1, AP-4, CCK-1a, c-Myc, CREB, Max1, USF1
                                                                           
  PRDX6_171715596   intron     A/G           c-Myb, c-Ets-2                n/a
                                                                           
  PRDX6_171716007   intron     A/G           n/a                           Sp1, C/EBPbeta, CACCC-binding factor
                                                                           
  PRDX6_171716572   intron     A/T           TMF, TFIID, ETF, TBP          n/a
                                                                           
  PRDX6_171716582   intron     A/G           GATA-1, GATA-3                n/a
                                                                           
  PRDX6_171716584   intron     A/T           GATA-1, GATA-3                SRY

\*Transcription factor binding site modeling was performed using TESS.

A Patrocles miRNA database search for *PRDX6*revealed eight SNPs in the 3\' UTR of *PRDX6*as potential miRNA binding sites (Table [6](#T6){ref-type="table"}). Of the eight SNPs returned from the search query, three matched SNPs from this study (rs4611, rs36005931, and rs2000). rs4611 and rs36005931 are located within octamers that have been conserved among several species, but do not correspond to a known miRNA. The G allele of rs2000 is part of an octamer capable of binding miR-942. A literature search for miR-942 returned only sequence data, with no known function to date.

###### 

PRDX6 SNPs thought to be miRNA target sites

  SNP ID       Chromosome Position   Base Change   Ancestral   Derived    miRNA
  ------------ --------------------- ------------- ----------- ---------- ----------------
  rs4611       171723640             T/C           TTGGTGCT               
                                                               CTGGTGCT   
                                                                          
  rs15268      171723695             C/A                       AGCAATTA   hsa-miR-302f
                                                               ATTACATA   hsa-miR-380
                                                                          
  rs3211528    171724201             G/A           CTGGGGGA               hsa-miR-361-3p
                                                                          
  rs36005931   171724224             A/G                       GTGCCTTC   
                                                               TGTGCCTT   
                                                                          
  rs35820016   171724277             T/A           TTTTGCTA               hsa-miR-548p
                                                               TTGCAATA   
                                                                          
  rs1804053    171724351             G/A                       ATGTAGCA   hsa-miR-221
                                                                          hsa-miR-222
                                                                          
  rs11544001   171724433             A/G                       GTGCATGA   
                                                               TGCATGAA   
                                                               TGTGCATG   
                                                                          
  rs2000       171724457             G/A           AGAGAAGA               hsa-miR-942

\*miRNA target site modeling was performed using Patrocles.

Association of *PRDX6*with ALI
------------------------------

The trauma cohort described in Table [1](#T1){ref-type="table"} was genotyped for 37 *PRDX6*SNPs using SNPlex. All SNPs were tested for Hardy-Weinberg equilibrium (Additional file [5](#S5){ref-type="supplementary-material"}). Chi^2^analysis of incidence of ALI compared to genotype using an additive model showed no significant association between any of the SNPs in this study and ALI (Table [7](#T7){ref-type="table"}). Dominant and recessive models failed to demonstrate an association between our SNPs of interest and ALI (Additional file [6](#S6){ref-type="supplementary-material"}). The genotype concordance rate based on assay positive controls was 100% and the frequency of missing genotypes is presented in Table [7](#T7){ref-type="table"}. Logistic regression analysis after adjustment for age and ISS showed no association between ALI and our SNPs (Table [8](#T8){ref-type="table"}).

###### 

Association of 37 PRDX6 genotypes and risk of ALI using and additive model in a population of African and European Americans with major trauma

                                  [European Americans]{.ul}   [African Americans]{.ul}                                                                                                                       
  ------------------ ------------ --------------------------- -------------------------- -------------------------------- ------------- --------------- ------------------- -------------------------------- -------------
  **SNP**            **Source**   **MAF (ALI)**               **MAF (non-ALI)**          **Missing Genotype Frequency**   **p value**   **MAF (ALI)**   **MAF (non-ALI)**   **Missing Genotype Frequency**   **p value**
                                                                                                                                                                                                             
  hCV1948447         Tagging      0.22                        0.20                       0.016                            0.538         0.06            0.05                0.019                            0.507
                                                                                                                                                                                                             
  hCV25599136        Tagging      0.00                        0.00                       0.161                            NA            0.03            0.03                0.230                            0.842
                                                                                                                                                                                                             
  hCV25599144        Tagging      0.00                        0.01                       0.399                            0.999         0.00            0.00                0.296                            NA
                                                                                                                                                                                                             
  hCV9040425         Tagging      0.27                        0.25                       0.021                            0.739         0.38            0.35                0.019                            0.725
                                                                                                                                                                                                             
  hCV9040434         Tagging      0.25                        0.24                       0.407                            0.838         0.31            0.29                0.307                            0.537
                                                                                                                                                                                                             
  Position23855054   Sequencing   0.00                        0.00                       0.012                            NA            0.09            0.08                0.019                            0.535
                                                                                                                                                                                                             
  Position23855203   Sequencing   0.00                        0.00                       0.679                            NA            0.10            0.17                0.662                            0.268
                                                                                                                                                                                                             
  Position23859396   Sequencing   0.00                        0.00                       0.012                            NA            0.04            0.02                0.019                            0.302
                                                                                                                                                                                                             
  Position23863249   Sequencing   0.00                        0.00                       0.012                            NA            0.03            0.03                0.023                            0.577
                                                                                                                                                                                                             
  PRDX6_171709910    Sequencing   0.03                        0.01                       0.436                            0.192         0.04            0.06                0.494                            0.505
                                                                                                                                                                                                             
  PRDX6_171711459    Sequencing   0.00                        0.00                       0.021                            NA            0.11            0.18                0.043                            0.088
                                                                                                                                                                                                             
  PRDX6_171713872    Sequencing   0.00                        0.01                       0.037                            0.999         0.08            0.05                0.070                            0.331
                                                                                                                                                                                                             
  PRDX6_171715019    Sequencing   0.00                        0.00                       0.029                            0.999         0.05            0.05                0.058                            0.879
                                                                                                                                                                                                             
  PRDX6_171724949    Sequencing   0.22                        0.19                       0.029                            0.455         0.07            0.05                0.043                            0.481
                                                                                                                                                                                                             
  rs10753081         Sequencing   0.34                        0.29                       0.008                            0.246         0.37            0.34                0.000                            0.676
                                                                                                                                                                                                             
  rs2000             Tagging      0.05                        0.05                       0.045                            0.966         0.02            0.02                0.031                            0.793
                                                                                                                                                                                                             
  rs33942654         Sequencing   0.23                        0.20                       0.021                            0.321         0.34            0.29                0.054                            0.138
                                                                                                                                                                                                             
  rs34129563         Sequencing   0.07                        0.03                       0.021                            0.080         0.01            0.01                0.039                            0.559
                                                                                                                                                                                                             
  rs34619706         Sequencing   0.08                        0.08                       0.037                            0.900         0.03            0.01                0.047                            0.287
                                                                                                                                                                                                             
  rs35244306         Sequencing   0.00                        0.01                       0.021                            0.999         0.11            0.08                0.039                            0.517
                                                                                                                                                                                                             
  rs35749242         Sequencing   0.00                        0.01                       0.021                            0.999         0.08            0.06                0.039                            0.516
                                                                                                                                                                                                             
  rs4354572          Sequencing   0.00                        0.00                       0.354                            NA            0.11            0.17                0.358                            0.251
                                                                                                                                                                                                             
  rs4382766          Sequencing   0.33                        0.29                       0.025                            0.312         0.35            0.34                0.047                            0.830
                                                                                                                                                                                                             
  rs4916362          Tagging      0.34                        0.29                       0.021                            0.308         0.35            0.32                0.019                            0.670
                                                                                                                                                                                                             
  rs57032935         Sequencing   0.23                        0.19                       0.037                            0.296         0.34            0.29                0.082                            0.131
                                                                                                                                                                                                             
  rs6671141          Sequencing   0.23                        0.19                       0.210                            0.421         0.38            0.33                0.163                            0.170
                                                                                                                                                                                                             
  rs6699179          Tagging      0.00                        0.00                       0.214                            NA            0.01            0.00                0.171                            0.999
                                                                                                                                                                                                             
  rs6702828          Tagging      0.00                        0.00                       0.012                            NA            0.01            0.00                0.027                            0.778
                                                                                                                                                                                                             
  rs6702835          Sequencing   0.27                        0.25                       0.008                            0.606         0.42            0.37                0.000                            0.493
                                                                                                                                                                                                             
  rs7314             Sequencing   0.27                        0.25                       0.045                            0.666         0.34            0.30                0.078                            0.571
                                                                                                                                                                                                             
  rs7367963          Tagging      0.34                        0.29                       0.029                            0.284         0.35            0.31                0.019                            0.574
                                                                                                                                                                                                             
  rs7521536          Tagging      0.24                        0.20                       0.025                            0.360         0.32            0.29                0.043                            0.320
                                                                                                                                                                                                             
  rs7529377          Tagging      0.24                        0.20                       0.016                            0.331         0.28            0.26                0.027                            0.321
                                                                                                                                                                                                             
  rs7540065          Sequencing   0.27                        0.25                       0.021                            0.726         0.37            0.35                0.039                            0.997
                                                                                                                                                                                                             
  rs912767           Tagging      0.24                        0.20                       0.016                            0.331         0.29            0.26                0.027                            0.240
                                                                                                                                                                                                             
  rs9425722          Sequencing   0.00                        0.00                       0.342                            NA            0.08            0.17                0.335                            0.048
                                                                                                                                                                                                             
  rs9425725          Tagging      0.00                        0.00                       0.012                            NA            0.13            0.20                0.027                            0.091

###### 

Multivariate analysis adjusted for age and injury severity score

                     African Americans   European Americans                                                                                                               
  ------------------ ------------------- -------------------- ----------- ---------- ----------- ---------- ------------- ------------ ----------- ---------- ----------- ----------
  **SNP**            **ORtrend**         **Ptrend**           **ORdom**   **Pdom**   **ORrec**   **Prec**   **ORtrend**   **Ptrend**   **ORdom**   **Pdom**   **ORrec**   **Prec**
                                                                                                                                                                          
  hCV1948447         1.33                0.507                1.19        0.705      3.87E+09    0.999      1.16          0.538        1.06        0.840      2.41        0.204
                                                                                                                                                                          
  hCV25599136        1.15                0.842                1.15        0.842      NA          NA         NA            NA           NA          NA         NA          NA
                                                                                                                                                                          
  hCV25599144        NA                  NA                   NA          NA         NA          NA         4.19E-10      0.999        4.19E-10    0.999      NA          NA
                                                                                                                                                                          
  hCV9040425         1.08                0.725                1.08        0.781      1.13        0.760      1.08          0.739        1.04        0.885      1.32        0.593
                                                                                                                                                                          
  hCV9040434         1.17                0.537                1.30        0.442      1.04        0.947      1.06          0.838        0.94        0.871      2.05        0.365
                                                                                                                                                                          
  Position23855054   1.25                0.535                1.39        0.398      2.07E-09    0.999      NA            NA           NA          NA         NA          NA
                                                                                                                                                                          
  Position23855203   0.56                0.268                0.60        0.374      1.52E-09    0.999      NA            NA           NA          NA         NA          NA
                                                                                                                                                                          
  Position23859396   1.73                0.302                2.17        0.190      1.70E-09    0.999      NA            NA           NA          NA         NA          NA
                                                                                                                                                                          
  Position23863249   1.36                0.577                1.61        0.431      1.70E-09    0.999      NA            NA           NA          NA         NA          NA
                                                                                                                                                                          
  PRDX6_171709910    0.66                0.505                0.72        0.636      1.74E-09    0.999      5.13          0.192        5.13        0.192      NA          NA
                                                                                                                                                                          
  PRDX6_171711459    0.58                0.088                0.61        0.146      2.02E-09    0.998      NA            NA           NA          NA         NA          NA
                                                                                                                                                                          
  PRDX6_171713872    1.49                0.331                1.69        0.229      1.06E-09    0.999      1.28E-09      0.999        1.28E-09    0.999      NA          NA
                                                                                                                                                                          
  PRDX6_171715019    0.93                0.879                1.01        0.989      1.07E-09    0.999      1.77E-09      0.999        1.77E-09    0.999      NA          NA
                                                                                                                                                                          
  PRDX6_171724949    1.35                0.481                1.21        0.681      4.18E+09    0.999      1.20          0.455        1.10        0.740      2.50        0.186
                                                                                                                                                                          
  rs10753081         1.09                0.676                1.19        0.543      0.98        0.970      1.28          0.246        1.34        0.288      1.44        0.439
                                                                                                                                                                          
  rs2000             1.21                0.793                1.21        0.793      NA          NA         0.98          0.966        1.25        0.661      1.30E-09    0.999
                                                                                                                                                                          
  rs33942654         1.39                0.138                1.78        0.057      1.05        0.923      1.27          0.321        1.14        0.640      2.96        0.103
                                                                                                                                                                          
  rs34129563         1.73                0.559                1.73        0.559      NA          NA         2.16          0.080        2.09        0.115      3.42E+09    0.999
                                                                                                                                                                          
  rs34619706         2.13                0.287                2.13        0.287      NA          NA         0.96          0.900        0.89        0.773      2.32        0.554
                                                                                                                                                                          
  rs35244306         1.25                0.517                1.41        0.349      1.34E-09    0.999      1.29E-09      0.999        1.29E-09    0.999      NA          NA
                                                                                                                                                                          
  rs35749242         1.30                0.516                1.43        0.399      1.09E-09    0.999      1.29E-09      0.999        1.29E-09    0.999      NA          NA
                                                                                                                                                                          
  rs4354572          0.65                0.251                0.70        0.386      1.85E-09    0.999      NA            NA           NA          NA         NA          NA
                                                                                                                                                                          
  rs4382766          0.96                0.830                0.94        0.838      0.94        0.892      1.24          0.312        1.26        0.409      1.50        0.394
                                                                                                                                                                          
  rs4916362          1.09                0.670                1.19        0.551      0.99        0.987      1.24          0.308        1.28        0.381      1.44        0.436
                                                                                                                                                                          
  rs57032935         1.40                0.131                1.81        0.053      1.07        0.888      1.29          0.296        1.16        0.600      2.98        0.101
                                                                                                                                                                          
  rs6671141          1.37                0.170                1.43        0.256      1.64        0.261      1.24          0.421        1.21        0.549      1.86        0.398
                                                                                                                                                                          
  rs6699179          1.14E+09            0.999                1.14E+09    0.999      NA          NA         NA            NA           NA          NA         NA          NA
                                                                                                                                                                          
  rs6702828          1.59                0.778                1.59        0.778      NA          NA         NA            NA           NA          NA         NA          NA
                                                                                                                                                                          
  rs6702835          1.15                0.493                1.78        0.063      0.61        0.242      1.12          0.606        1.12        0.686      1.28        0.632
                                                                                                                                                                          
  rs7314             1.13                0.571                1.26        0.437      1.02        0.963      1.10          0.666        1.07        0.820      1.38        0.542
                                                                                                                                                                          
  rs7367963          1.12                0.574                1.13        0.676      1.26        0.589      1.26          0.284        1.30        0.347      1.45        0.432
                                                                                                                                                                          
  rs7521536          1.24                0.320                1.47        0.191      1.01        0.977      1.24          0.360        1.11        0.705      2.95        0.104
                                                                                                                                                                          
  rs7529377          1.25                0.321                1.31        0.360      1.40        0.506      1.26          0.331        1.14        0.651      2.93        0.106
                                                                                                                                                                          
  rs7540065          1.00                0.997                1.03        0.922      0.95        0.896      1.08          0.726        1.04        0.883      1.35        0.570
                                                                                                                                                                          
  rs912767           1.30                0.240                1.40        0.250      1.40        0.505      1.26          0.331        1.14        0.651      2.93        0.106
                                                                                                                                                                          
  rs9425722          0.44                0.048                0.44        0.065      1.97E-09    0.999      NA            NA           NA          NA         NA          NA
                                                                                                                                                                          
  rs9425725          0.60                0.091                0.63        0.154      2.03E-09    0.998      NA            NA           NA          NA         NA          NA

Haplotype Analysis
------------------

Haplotype blocks were created for both African and European Americans using 27 and 28 SNP markers, respectively. Haplotype blocks were created for a region spanning 100.6 kb of chromosome 1. For African Americans, there were 14 SNP markers with genotyping completion rate of less than 95% and were thus excluded from the haplotype analysis. For European Americans, there were 9 SNPs with a genotype completion rate of less than 95% and were excluded from the haplotype analysis.

In African Americans, there were 2 blocks (block1 = rs4916362 and rs10753081; block2 = *PRDX6*\_171711459, rs34619706, hCV9040425, rs35244306, rs9425725, rs912767, rs2000, hCV1948447, rs6702828, rs6702835, rs7521536, rs7529377) (Figure [2](#F2){ref-type="fig"}). In European Americans, there were 2 blocks (block1 = rs4916362, rs10753081, PRDX6_171711459, rs34619706; block2 = rs33942654, PRDX6_171715019, hCV9040425, rs35244306, rs9425725, rs912767, rs2000, hCV1948447, rs6702835, rs7521536, rs7529377) (Figure [3](#F3){ref-type="fig"}). The haplotype structure of *PRDX6*appears to be in low LD, in both subgroups. Haplotype analyses of association with ALI did not reveal any significant associations above and single SNP analyses (Table [9](#T9){ref-type="table"}).

![**Haplotype Structure of 17 PRDX6 SNPs in African Americans with r^2^Values (N = 259)**.](1471-2350-12-77-2){#F2}

![**Haplotype Structure of 17 PRDX6 SNPs in European Americans with r^2^Values (N = 254)**.](1471-2350-12-77-3){#F3}

###### 

Haplotype Analysis among African and European Americans

  African Americans   European Americans                                                                                                       
  ------------------- -------------------- ---------------------------- ------------- ----------- --------------- ---------------------------- -------------
  **Block**           **Haplotype**        **Population Frequencies**   **p value**   **Block**   **Haplotype**   **Population Frequencies**   **p value**
                                                                                                                                               
  Block 1             GT                   0.654                        0.719         Block 1     ACA             0.690                        0.520
                                                                                                                                               
                      AC                   0.330                        0.833                     GTA             0.230                        0.479
                                                                                                                                               
                      GC                   0.016                        0.563                     GTG             0.080                        0.999
                                                                                                                                               
  Block 2             TGTTACGTG            0.282                        0.449         Block 2     GGACGTG         0.734                        0.883
                                                                                                                                               
                      TATTGCACA            0.212                        0.386                     AAGTACA         0.202                        0.634
                                                                                                                                               
                      CATCACATG            0.153                        0.083                     GAACATG         0.050                        0.297
                                                                                                                                               
                      TACTACGTG            0.099                        0.485                                                                  
                                                                                                                                               
                      TGTTACATG            0.072                        0.455                                                                  
                                                                                                                                               
                      TATTACATG            0.055                        0.935                                                                  
                                                                                                                                               
                      TATTGTACA            0.051                        0.894                                                                  
                                                                                                                                               
                      TATTACACG            0.036                        0.969                                                                  
                                                                                                                                               
                      TATCACATG            0.028                        0.953                                                                  

Discussion
==========

Prdx6 is a member of the thiol-specific antioxidant protein family and in overexpressing cell and mouse models has been shown to be protective against oxidant stress which null models show sensitivity to oxidants \[[@B7],[@B9],[@B27]\]. Thus, *PRDX6*is a suitable candidate gene for ALI risk. The extent of genetic variation within *PRDX6*remains largely unknown, therefore we performed direct sequencing of the *PRDX6*gene, and identified novel variants for future study. We also tested the newly discovered SNPs and tagging SNPs for association with ALI using our trauma cohort, and did not demonstrate an association with trauma-related ALI.

We identified 43 novel variants among African American and European American subjects with either ALI or control status. None of the 43 SNPs identified were in coding regions which may indicate that the Prdx6 protein is highly conserved across phyla. Approximately 19 kb on chromosome 1 was sequenced in order to achieve adequate coverage of the *PRDX6*gene and flanking 5\' and 3\' UTRs. Special attention was given to the GRE2 and ARE1 regions -749 to -737 and -357 to -349, respectively. The ARE1 within the *PRDX6*promoter was shown to play a role in regulation of transcription and to be inducible under conditions of oxidative stress \[[@B26]\] and the GRE2 may be capable of binding transcription factors under oxidative stress conditions \[[@B28]\]. Due to the GC rich content of the region surrounding the ARE1, we were unable to optimize PCR reaction conditions in a way to prime through the secondary structure. The GRE2 region was sequenced, but no variation was noted. The GC rich region within the *PRDX6*promoter might warrant further investigation since methylation of DNA cytosine residues are often found in the sequence context CpG. Several new sequencing approaches are emerging that target methylation sites using restriction enzyme treatment followed by sequence by synthesis \[[@B29]\].

In addition to comparing our results with NCBI\'s dbSNP, we compared our novel and known SNPs with the resequencing data registered in 1000 Genomes. The 1000 Genomes project aims to find most genetic variants with frequencies of at least 1%. Thus far three sequencing projects contribute to the database, low coverage sequencing of 179 individuals from 4 populations, high coverage sequencing of 2 mother-father-child trios, and exon targeting sequencing of 697 individuals from 7 populations \[[@B30]\]. Although 1000 Genomes aims to identify over 95% of variation in any individual, 27 of our novel SNPs and 1 previously recorded SNP are not present in the database, signifying a need for resequencing of extreme phenotypes, such as ALI cases.

Novel and previously recorded SNPs in the 5\' UTR and first intron of *PRDX6*were submitted to TESS to determine their likelihood of being in transcription factor binding sites. We found 19 motifs in the reference sequences that are capable of binding known transcription factors and 21 in the alternative sequence. A comparison between the results of the reference sequence search and the alternative revealed that in most cases, the SNP of interest changes the motif enough to cause a different transcription factor to bind that site or can cause a binding site to disappear and vice versa. After comparison with the ENCODE data, we found that our sequences have not yet been shown to bind the three overlapping transcription factors tested in ENCODE experimentally.

Known SNPs validated in the sequencing effort were compared using a Patrocles search query for miRNA target sites within *PRDX6*to determine if any of our SNPs were in putative target sites for miRNAs. Three of the eight SNPs returned from the search corresponded with our known SNPs. Only one of the three SNPs was found to have a corresponding known miRNA (miR-942). Some miRNAs are known to control the expression of genes at the posttranscriptional level \[[@B31]\]. However, very limited data are available on miR-942.

We performed an association study for ALI using newly uncovered SNPs and SNPs selected from Hapmap and NCBI\'s dbSNP and observed no significant association between any of the SNPs in this study and ALI. This lack of association may be due to several causes. First, the detectable effect size is modest because of sample size limitations. We genotyped 513 subjects to test for an association between our selected SNPs and ALI, but this sample size was inadequate to detect relative risks below 1.93 and 1.69 for alleles with MAFs of 0.05 and 0.10, respectively. Second, our analyses were limited to patients with severe trauma. Thus, our study did not evaluate a possible association with other causes of ALI such as sepsis. Finally, it is possible that *PRDX6*genetic variation may not modify the risk of ALI.

The genotype data were used to construct haplotype blocks to better assess the *PRDX6*gene structure. Haplotype analysis plays an important role in association studies between genotype and phenotype, since SNPs found to be in strong LD can capture most of the genetic variation across fairly large regions \[[@B24]\]. The haplotype blocks constructed from our genotype data did not show strong linkage disequilibrium using confidence intervals, therefore tagging SNP strategies in future studies should be approached with caution.

Our resequencing data did not show any variation in the coding region of PRDX6. Had nonsynonymous SNPs been discovered, it would have prompted us to investigate whether any of these SNPs had any effect on protein structure, which could cause a loss of function in Prdx6. Since we cannot make a connection between coding region SNPs and conformational changes in the protein, we examined regulatory effects. We found several promoter SNPs that change the sequence of potential TFBSs based on conservation data. We were unable to confirm that these sequences were in fact TFBSs due to the lack of available data. However if any of our promoter SNPs showed a significant association with ALI or another phenotype perhaps using a larger sample size, future studies using promoter constructs could offer more information on upregulation of PRDX6. We also found several SNPs in the 3\'UTR. It is possible that one or more of these SNPs is responsible for changing an miRNA binding site, thus repressing protein translation.

Our study has several limitations. One potential limitation of this study is the number of genotype call failures. Ten and nine markers for African Americans and European Americans respectively were eliminated from our analysis since they were under the 95% completion rate cut-off. This high rate of genotype failure was due to difficulties with consistent assay performance rather than DNA quality. If these genotypes had been obtained, it is a possible that an association may have been observed. Also, we did not adjust our results for ancestry informative markers (AIMs). Instead our population was stratified based on skin color, which may not be an adequate proxy for population admixture effects. Another possible limitation is a candidate gene approach that focused on a single gene: *PRDX6*. ALI risk may be considered a complex phenotype, and thus likely is not fully explained by a variation in a single gene \[[@B10]\]. Finally, we only tested for association in patients with ALI from severe trauma. Thus, it is possible that *PRDX6*may play a role in the initiation or severity of ALI after other insults, including sepsis, or in determining recovery from ALI.

PRDX6 has been shown to play a role not only in ALI, but other diseases as well. A recent studied demonstrated that PRDX6 promotes lung cancer metastasis and invasion via phospholipase A~2~activity in mice \[[@B32]\]. Another publication reported that PRDX6 transfected breast cancer cells metastasized more readily to the lungs when compared with control cells \[[@B26]\]. It is possible that our novel SNPs may function in lung cancer as well as ALI. The interaction between GSTpi and PRDX6 is another interesting subject for future studies. GSTpi expression is elevated in tumors from a variety of cancers, including lung cancer, compared to normal tissue \[[@B33]\]. Testing gene-gene interactions between PRDX6 and GSTpi would be an interesting future direction both in ALI and other diseases such as cancer.

Conclusion
==========

In conclusion, this study revealed novel SNPs within the important anti-oxidant *PRDX6*gene and its 5\' and 3\' flanking regions via direct sequencing. Several of these variants have putative function and may be useful for future gene association studies. Although there was no association discovered between our novel and tagging SNPs with trauma-related ALI, future studies may focus on the role of *PRDX6*variation in other at risk groups, as well as other diseases.
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